Clinical Trials Logo

Filter by:
NCT ID: NCT03959527 Active, not recruiting - Gonorrhea Clinical Trials

Zoliflodacin in Uncomplicated Gonorrhoea

Start date: November 6, 2019
Phase: Phase 3
Study type: Interventional

This trial is a multi-center, open label, randomized controlled, non-inferiority phase III trial evaluating the safety and efficacy of a 3 g oral dose of zoliflodacin compared to a combination of a single intra-muscular 500 mg dose of ceftriaxone and a single 1 g oral dose of azithromycin for the treatment of uncomplicated gonorrhoea.

NCT ID: NCT03959111 Active, not recruiting - Low Back Pain Clinical Trials

Auricular Acupuncture Stimulation for Chronic Pain

Start date: October 17, 2019
Phase: N/A
Study type: Interventional

This proposal aims to investigate the treatment effect and underlying mechanism of transcutaneous acupuncture stimulation on chronic low back pain. We believe that this study, if successful, will provide new treatment options for chronic low back pain, reduce the use of opioid analgesics in chronic pain management, and enhance our understanding of the underlying mechanism of nerve stimulation treatment, as well as the pathophysiology and development of chronic pain.

NCT ID: NCT03958045 Active, not recruiting - Clinical trials for Small Cell Lung Cancer

Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma

Start date: September 4, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate survival and response rate of the combination rucaparib and nivolumab as maintenance therapy in platinum-sensitive small cell lung carcinoma.

NCT ID: NCT03957252 Active, not recruiting - Prostate Cancer Clinical Trials

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

APCaRI-05
Start date: June 6, 2019
Phase:
Study type: Observational

This study is designed to determine the accuracy of blood test ClarityDX Prostate to predict the results of prostate biopsies in men who have PSA (Prostate Specific Antigen) greater or equal to 3 ng/mL.

NCT ID: NCT03956277 Active, not recruiting - Gastrostomy Clinical Trials

Single-center, Feasibility Study to Evaluate the Use and Safety of the Percutaneous Ultrasound Gastrostomy Technique

Start date: December 1, 2019
Phase:
Study type: Observational

This is a single-center, non-randomized, non-blinded feasibility study to evaluate the performance, safety and tolerability of the Percutaneous Ultrasound Gastrostomy (PUG) procedure that utilizes a novel device in conjunction with widely available ultrasound technology. The procedure will be performed in 40eligible subjects. Patients will be followed for 2 days following performance of PUG to assess for potential complications. If the patient remains hospitalized they will be assessed through Day30 for potential complications.

NCT ID: NCT03956095 Active, not recruiting - Clinical trials for Debulking Surgery for Ovarian Cancer

Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer

Start date: May 16, 2019
Phase:
Study type: Observational

The purpose of this study is to find out if it is possible to establish a nutritional support program for people who are scheduled to receive primary debulking surgery. Design: This will be a prospective observational study to assess the feasibility of implementing a preoperative nutrition supplementation program.

NCT ID: NCT03956017 Active, not recruiting - Myocardial Injury Clinical Trials

Anti-oxidant Therapy and Postoperative Cardiac Events (ACE) Trial, Preoperative Intervention in Vascular Surgery

ACE
Start date: August 5, 2013
Phase: Early Phase 1
Study type: Interventional

N Terminal (NT)-Pro b-type natriuretic peptide (BNP) levels provide incremental value in perioperative risk assessment prior to major non-cardiac surgery. The investigators will test whether pharmacologically lowering this biomarker with daily administration of CoQ10 for 3 days prior to elective vascular surgery will reduce adverse outcomes following the operation.

NCT ID: NCT03955991 Active, not recruiting - Stress Clinical Trials

VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)

VSMART
Start date: July 21, 2016
Phase: Phase 4
Study type: Interventional

The proposed study tests the effects of a novel remotely-delivered group cognitive behavioral stress management (R-CBSM) intervention on improving health and quality of life in older women undergoing breast cancer (BCa) treatment. This study tests if delivered home-based group CBSM (R-CBSM) improves response to influenza vaccine (IV) in parallel with improved psychological adaptation, inflammation and other immune functioning indicators in older women treated for BCa.

NCT ID: NCT03955783 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

Start date: June 21, 2019
Phase: Phase 1
Study type: Interventional

This phase Ib trial studies the toxicity and dosing of venetoclax in combination with selinexor, and how well the combination works in treatment of patients with high risk hematologic malignancies such as diffuse large B-cell lymphoma and acute myeloid leukemia that has come back (recurrent) or does not respond to initial treatment (refractory). Venetoclax functions by inhibiting a protein in the body called bcl-2, which is involved in slowing down the normal process by which old cells in the body are cleared (called apoptosis). Selinexor functions by trapping "tumor suppressing proteins" within the cell and causing the cancer cells to die or stop growing. This study examines the effects, if any, of selinexor and venetoclax on high risk hematologic malignancies and on the body, including any side-effects.

NCT ID: NCT03955757 Active, not recruiting - Primary Prevention Clinical Trials

Using Boot Camp Translation to Address Rural Disparities in Adolescent Vaccination

RADVax
Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The overall goal of this project is to implement the Boot Camp Translation process to develop a replicable approach for increasing adolescent vaccine uptake that can be adaptable and feasible to use in rural settings more broadly.